Long-Term Study of COVID-19 Infection and Long COVID
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- University of North Carolina, Chapel Hill
- Study ID
- NCT07781501
- Status
- Recruiting
Conditions
- SARS CoV-2 Post-Acute Sequelae
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- This study is observational. Only patients who have previously tested positive for SARS-CoV-2 infection or are experiencing ongoing symptoms. — OTHEROther:
Study Details
This study will examine how common Long COVID is and how symptoms may persist over time in people who have previously had COVID-19. Researchers will collect information about participants' health and symptoms through questionnaires and may collect saliva and other non-invasive oral samples. The study will also examine biological factors in these samples that may be associated with persistent symptoms. The goal is to better understand why some people develop Long COVID and identify factors that may help predict who is more likely to experience persistent symptoms.
Key Dates
- First listed
- Aug 24, 2026
- Start date
- Sep 4, 2024
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: COVID-19+Adults who have previously had COVID-19 and may be experiencing ongoing symptoms or changes in their health following infection.
Primary Outcome Measure
Salivary Proteomic Profile [ Time Frame: During active infection through three months post infection ]
Central Contacts
- Laura A Jacox, PhD, DMD, MS+1 847-702-0988
- Jeannene L Matthews, MA, M.Ed., CCC-SLP+1 919-357-5999
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of North Carolina | Chapel Hill | North Carolina | 27599-7555 | Laura A Jacox, PhD, DMD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chapel Hill, NC
By research site
Related Studies
- Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionEARLY_PHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama